Treatment of Acute Myeloid Leukemia in Suspected Acute Promyelocytic Leukaemia

When acute myeloid leukemia presents with features raising suspicion for acute promyelocytic leukaemia (APL), this specific clinical situation requires a time-sensitive, targeted management approach — one that begins before confirmatory results are in hand.

Clinical scenario

Suspected acute promyelocytic leukaemia — APL is the working diagnosis, and confirmatory molecular and/or cytogenetic results are still pending.

Treatment approach

Evidence-based guidance supports the immediate initiation of ATRA (all-trans-retinoic acid) in this setting — the full protocol details continuation criteria and the complete management pathway once confirmatory results become available.

Instant Access to Structured Evidence-Based Regimens

References

In patients in whom APL is suspected, immediate treatment with ATRA should be initiated, until confirmatory molecular and/or cytogenetic results are available [V, A].

View source ↗